Replies to post #209994 on Biotech Values

[DewDiligence]

GNMX's PR mentions a lot of ancillary p-values—but not the p-value for the missed primary endpoint!

I presume that someone must have asked about this on the CC this morning.

[DewDiligence]

GNMX fails again in ADHD:

https://www.prnewswire.com/news-releases/aevi-genomic-medicine-announces-top-line-results-from-placebo-controlled-ascend-trial-parts-a--b-of-aevi-001-in-children-with-adhd-300772052.html